Cibus, Inc.

Cibus develops proprietary plant traits using precision gene editing technologies, particularly its Rapid Trait Development System and Trait Machine process. The enterprise focuses primarily on licensing productivity traits, such as weed management and disease resistance, directly into seed companies' elite germplasm for royalty fees. Key agricultural programs target rice herbicide tolerance alongside trait initiatives across crops like canola, soybean, and wheat. Beyond core crop genetics, the organization maintains a sustainable ingredients line producing bio-based fragrance products through yeast fermentation for consumer packaged goods companies. Its customer base includes global seed producers and multinational corporate partners.

The entity maintains core operational activities and headquarters in San Diego, California, having streamlined staff and wound down a facility in Roseville, Minnesota. Its geographic footprint and commercial relationships span seed partners and field research programs across the United States, Latin America, Europe, the United Kingdom, and India.

Summary of the business section of Cibus's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of December 31, 2025, Cibus had 118 full-time employees, including a total of 29 employees with Ph.D.”